| Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial P Tabarsi, S Barati, H Jamaati, S Haseli, M Marjani, A Moniri, Z Abtahian, ... International immunopharmacology 90, 107205, 2021 | 96 | 2021 |
| Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial F Dastan, SA Nadji, A Saffaei, M Marjani, A Moniri, H Jamaati, ... International immunopharmacology 85, 106688, 2020 | 90 | 2020 |
| A review of medication errors in iran: sources, underreporting reasons and preventive measures A Mansouri, A Ahmadvand, M Hadjibabaie, M Javadi, SH Khoee, ... Iranian journal of pharmaceutical research: IJPR 13 (1), 3, 2014 | 86 | 2014 |
| No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial H Jamaati, SMR Hashemian, B Farzanegan, M Malekmohammad, ... European Journal of Pharmacology 897, 173947, 2021 | 85 | 2021 |
| Promising effects of tocilizumab in COVID-19: a non-controlled, prospective clinical trial F Dastan, A Saffaei, S Haseli, M Marjani, A Moniri, Z Abtahian, A Abedini, ... International immunopharmacology 88, 106869, 2020 | 63 | 2020 |
| A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol H Jamaati, F Dastan, P Tabarsi, M Marjani, A Saffaei, SMR Hashemian IJPR, 2020 | 51 | 2020 |
| Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19 F Dastan, A Saffaei, SM Mortazavi, H Jamaati, N Adnani, S Samiee Roudi, ... Journal of global antimicrobial resistance 21, 340-341, 2020 | 46 | 2020 |
| Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial R Malekzadeh, A Abedini, B Mohsenpour, E Sharifipour, R Ghasemian, ... International Immunopharmacology 89, 107102, 2020 | 42 | 2020 |
| Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis F Fahimi, P Tabarsi, F Kobarfard, BD Bozorg, A Goodarzi, F Dastan, ... The International journal of tuberculosis and lung disease 17 (12), 1602-1606, 2013 | 37 | 2013 |
| Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis S Rezaei, B Fatemi, Z Karimi Majd, H Minaei, M Peikanpour, N Anjidani, ... Expert review of clinical immunology 17 (5), 499-511, 2021 | 35 | 2021 |
| Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial A Fakharian, S Barati, M Mirenayat, M Rezaei, S Haseli, P Torkaman, ... International immunopharmacology 99, 107961, 2021 | 31 | 2021 |
| Efficacy and safety of propolis mouthwash in management of radiotherapy induced oral mucositis; A randomized, double blind clinical trial F Dastan, A Ameri, S Dodge, HH Shishvan, A Pirsalehi, M Abbasinazari Reports of Practical Oncology & Radiotherapy 25 (6), 969-973, 2020 | 27 | 2020 |
| Role of Vitamin D Replacement on Health Related Quality of Life in Hospitalized Patients with" Acute Exacerbation of Chronic Obstructive Pulmonary Disease" MH Pourrashid, F Dastan, J Salamzadeh, A Eslaminejad, M Edalatifard Iranian journal of pharmaceutical research: IJPR 17 (2), 801, 2018 | 26 | 2018 |
| Effect of bromhexine in hospitalized patients with COVID-19 R Tolouian, ZD Mulla, H Jamaati, A Babamahmoodi, M Marjani, ... Journal of Investigative Medicine 71 (7), 691-699, 2023 | 23 | 2023 |
| A comparative study of the analgesic effects of intravenous ketorolac, paracetamol, and morphine in patients undergoing video-assisted thoracoscopic surgery: A double-blind … F Dastan, ZM Langari, J Salamzadeh, A Khalili, S Aqajani, A Jahangirifard Annals of Cardiac Anaesthesia, 2020 | 22 | 2020 |
| A case report of hearing loss post use of hydroxychloroquine in a HIV-infected patient H Khalili, F Dastan, SA Dehghan Manshadi DARU Journal of Pharmaceutical Sciences 22, 1-4, 2014 | 22 | 2014 |
| Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients P Baghaei, F Dastan, M Marjani, A Moniri, Z Abtahian, S Ghadimi, ... International Immunopharmacology 92, 107329, 2021 | 20 | 2021 |
| Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces F Dastan, PT email, M Marjani, A Moniri, SMR Hashemian, ... IJPR, 2020 | 20 | 2020 |
| Symptom prediction and mortality risk calculation for COVID-19 using machine learning E Jamshidi, A Asgary, N Tavakoli, A Zali, F Dastan, A Daaee, ... Frontiers in artificial intelligence 4, 673527, 2021 | 19 | 2021 |
| Randomized trial of carnitine for the prevention of perioperative atrial fibrillation F Dastan, AH Talasaz, M Mojtahedzadeh, A Karimi, A Salehiomran, ... Seminars in thoracic and cardiovascular surgery 30 (1), 7-13, 2018 | 19 | 2018 |
